Patient-based cost-effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4-year prospective randomised phase II study.
暂无分享,去创建一个
F. Bi | Pengfei Zhang | F. Wen | Jing Zhou | Qiu Li | Hanrui Zheng | K. Zhou | Hongdou Chen